Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Quarterly results
CC transcript
|
|
MEDICIS PHARMACEUTICAL CORP (MRX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/11/2012 |
8-K
| Quarterly results |
| 11/28/2012 |
8-K
| Other Events |
| 11/21/2012 |
8-K
| Other Events |
| 11/05/2012 |
8-K
| Other Events |
| 10/17/2012 |
8-K
| Other Events |
| 10/09/2012 |
8-K
| Other Events |
| 09/25/2012 |
8-K
| Other Events |
| 09/04/2012 |
8-K
| Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits|
Docs:
|
"Agreement and Plan of Merger, among Medicis Pharmaceutical Corporation, Valeant Pharmaceuticals International, Valeant Pharmaceuticals International, Inc. and Merlin Merger Sub, Inc",
"Settlement Agreement, between Medicis Pharmaceutical Corporation and Deutsche Bank AG, London Branch",
"VALEANT PHARMACEUTICALS INTERNATIONAL, INC. AGREES TO ACQUIRE MEDICIS PHARMACEUTICAL CORPORATION FOR $44.00 PER SHARE IN CASH Combination Creates a Global Leader in Dermatology Transaction Values Medicis at Approximately $2.6 Billion At Least $225 Million Run Rate in Annual Cost Synergies Expected to be Achieved within 6 Months of Closing Transaction Expected to Close in the First Half of 2013",
"Medicis Pharmaceutical Corporation communications" |
|
| 08/08/2012 |
8-K
| Quarterly results |
| 07/23/2012 |
8-K
| Form 8-K - Current report |
| 06/06/2012 |
8-K
| Other Events |
| 05/21/2012 |
8-K
| Other Events |
| 05/16/2012 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...|
Docs:
|
"Underwriting Agreement, by and among Medicis Pharmaceutical Corporation and Deutsche Bank Securities Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters listed in Schedule II thereto",
"Indenture, between Medicis Pharmaceutical Corporation and Deutsche Bank Trust Company Americas, as trustee",
"First Supplemental Indenture, between Medicis Pharmaceutical Corporation and Deutsche Bank Trust Company Americas, as trustee, including the form of Medicis Pharmaceutical Corporation's 1.375% Convertible Senior Notes due 2017",
"Opinion of Latham & Watkins LLP",
"Base Note Hedge Transaction Confirmation, by and between Medicis Pharmaceutical Corporation and Deutsche Bank AG, London Branch",
"Base Note Hedge Transaction Confirmation, by and between Medicis Pharmaceutical Corporation and JPMorgan Chase Bank, National Association, London Branch",
"Base Warrant Transaction Confirmation, by and between Medicis Pharmaceutical Corporation and Deutsche Bank AG, London Branch",
"Base Warrant Transaction Confirmation, by and between Medicis Pharmaceutical Corporation and JPMorgan Chase Bank, National Association, London Branch",
"Additional Note Hedge Transaction Confirmation, by and between Medicis Pharmaceutical Corporation and Deutsche Bank AG, London Branch",
"Additional Note Hedge Transaction Confirmation, by and between Medicis Pharmaceutical Corporation and JPMorgan Chase Bank, National Association, London Branch" |
|
| 05/11/2012 |
8-K
| Other Events, Financial Statements and Exhibits |
| 05/08/2012 |
8-K
| Quarterly results |
| 05/02/2012 |
8-K
| Other Events |
| 03/28/2012 |
8-K
| Form 8-K - Current report |
| 03/02/2012 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 02/27/2012 |
8-K
| Form 8-K - Current report |
| 02/16/2012 |
8-K/A
| Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits|
Docs:
|
"Consent of KPMG LLP",
"Audited consolidated financial statements of Graceway Pharma Holding Corp. and Subsidiaries as of December 31, 2010 and 2009 and for the years ended December 31, 2010, 2009 and 2008 and the notes related thereto",
"Unaudited condensed consolidated financial statements of Graceway Pharma Holding Corp. and Subsidiaries as of September 30, 2011 and December 31, 2010 and for the interim periods ended September 30, 2011 and 2010 and the notes related thereto",
"Unaudited pro forma condensed combined financial information of the Company and Graceway Pharma Holding Corp. and Subsidiaries for the year ended December 31, 2010 and as of and for the nine months ended September 30, 2011 and the notes related thereto" |
|
| 12/02/2011 |
8-K
| Form 8-K - Current report |
| 11/23/2011 |
8-K
| Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits |
| 11/08/2011 |
8-K
| Form 8-K - Current report |
| 09/20/2011 |
8-K
| Entry into a Material Definitive Agreement |
| 09/15/2011 |
8-K
| Entry into a Material Definitive Agreement |
| 09/08/2011 |
8-K/A
| Submission of Matters to a Vote of Security Holders |
| 08/10/2011 |
8-K
| Form 8-K - Current report |
| 08/08/2011 |
8-K
| Quarterly results |
| 06/30/2011 |
8-K
| Form 8-K - Current report |
| 06/01/2011 |
8-K
| Other Events |
| 05/23/2011 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/05/2011 |
8-K
| Form 8-K - Current report |
| 04/11/2011 |
8-K
| Other Events |
| 04/05/2011 |
8-K
| Form 8-K - Current report |
|
|
|